Chng WJ - Search Results

1

SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple Myeloma.

Chong PSY, Chooi JY, Lim JSL, Toh SHM, Tan TZ, Chng WJ. Chong PSY, et al. Among authors: chng wj. Cancer Res. 2021 May 1;81(9):2332-2344. doi: 10.1158/0008-5472.CAN-20-2946. Epub 2021 Feb 18. Cancer Res. 2021. PMID: 33602783

2

Targeted therapy in multiple myeloma.

Chng WJ, Lau LG, Yusof N, Mow BM. Chng WJ, et al. Cancer Control. 2005 Apr;12(2):91-104. doi: 10.1177/107327480501200204. Cancer Control. 2005. PMID: 15855892 Free article. Review.

3

Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.

Chng WJ, Kumar S, Vanwier S, Ahmann G, Price-Troska T, Henderson K, Chung TH, Kim S, Mulligan G, Bryant B, Carpten J, Gertz M, Rajkumar SV, Lacy M, Dispenzieri A, Kyle R, Greipp P, Bergsagel PL, Fonseca R. Chng WJ, et al. Cancer Res. 2007 Apr 1;67(7):2982-9. doi: 10.1158/0008-5472.CAN-06-4046. Cancer Res. 2007. PMID: 17409404 Clinical Trial.

4

Curcumin sensitizes acute promyelocytic leukemia cells to unfolded protein response-induced apoptosis by blocking the loss of misfolded N-CoR protein.

Ng AP, Chng WJ, Khan M. Ng AP, et al. Among authors: chng wj. Mol Cancer Res. 2011 Jul;9(7):878-88. doi: 10.1158/1541-7786.MCR-10-0545. Epub 2011 May 20. Mol Cancer Res. 2011. PMID: 21602299

5

miRNA deregulation in multiple myeloma.

Bi CL, Chng WJ. Bi CL, et al. Among authors: chng wj. Chin Med J (Engl). 2011 Oct;124(19):3164-9. Chin Med J (Engl). 2011. PMID: 22040573 Review.

6

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia.

Zhou J, Cheong LL, Liu SC, Chong PS, Mahara S, Bi C, Ong KO, Zeng Q, Chng WJ. Zhou J, et al. Among authors: chng wj. Mol Cancer. 2012 Sep 21;11:72. doi: 10.1186/1476-4598-11-72. Mol Cancer. 2012. PMID: 22995644 Free PMC article.

7

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer.

Chan D, Zheng Y, Tyner JW, Chng WJ, Chien WW, Gery S, Leong G, Braunstein GD, Koeffler HP. Chan D, et al. Among authors: chng wj. J Cancer Res Clin Oncol. 2013 Sep;139(9):1507-14. doi: 10.1007/s00432-013-1465-6. Epub 2013 Jul 4. J Cancer Res Clin Oncol. 2013. PMID: 23824064 Free PMC article.

8

Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in T(4;14) multiple myeloma.

Xie Z, Gunaratne J, Cheong LL, Liu SC, Koh TL, Huang G, Blackstock WP, Chng WJ. Xie Z, et al. Among authors: chng wj. Oncotarget. 2013 Jul;4(7):1008-18. doi: 10.18632/oncotarget.1049. Oncotarget. 2013. PMID: 23900284 Free PMC article.

9

Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival.

Reghunathan R, Bi C, Liu SC, Loong KT, Chung TH, Huang G, Chng WJ. Reghunathan R, et al. Among authors: chng wj. Oncotarget. 2013 Aug;4(8):1230-40. doi: 10.18632/oncotarget.1145. Oncotarget. 2013. PMID: 23985559 Free PMC article.

10

Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model.

Siveen KS, Mustafa N, Li F, Kannaiyan R, Ahn KS, Kumar AP, Chng WJ, Sethi G. Siveen KS, et al. Among authors: chng wj. Oncotarget. 2014 Feb 15;5(3):634-48. doi: 10.18632/oncotarget.1596. Oncotarget. 2014. PMID: 24504138 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

375 results

Search Page